Clinical Trial

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

Name: A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors. — clinical trial record (NCT07392736)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This trial is an open, non-randomized, phase I/IIa clinical trial, which will evaluate the preliminary effectiveness and safety of AL8326 tablets in patients with advanced solid tumors

Trial Details

NCT Number	NCT07392736
Lead Sponsor	Advenchen Laboratories, LLC
Conditions	Solid Tumor
Enrollment	228 participants
Start Date	2021-10-26
Primary Completion	2029-11-07 (estimated)
Study Completion	2029-11-07 (estimated)
Updated on ClinicalTrials.gov	2026-02-06